Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with increased revenue, net income, and dividend growth. The company has a balanced capital structure and plans for further acquisition growth. The Q&A section reveals proactive management strategies, including refinancing plans and strategic divestitures. Despite some unclear responses, the overall sentiment from the earnings and Q&A is positive, bolstered by dividend increases and acquisition plans. The lack of negative sentiment in analyst questions and management's optimistic outlook suggest a positive stock price movement in the short term.
Total Assets $880 million, a 33.1% increase compared to Q3 2024. This growth is primarily driven by acquisition strategy and successful retenanting of specific leasing.
Year-to-date Revenue $114.9 million, up $28.3 million versus September of last year. This increase is largely due to the timing and integration of properties acquired over the past year, as well as retenanting activity.
Net Income (Year-to-date) $24.5 million or $0.44 a share, compared to $19.9 million or $0.40 a share last year. The increase is attributed to acquisitions and lease transitions.
Quarterly Revenue Increased by $10.2 million year-over-year, driven by acquisitions and lease transitions.
Quarterly Net Income $8.8 million or $0.16 a share, up from $6.9 million or $0.14 per share in Q3 2024. The increase is due to acquisitions and lease transitions.
AFFO (Adjusted Funds From Operations) Projected at $72.7 million for 2025, a 28.2% increase over the last year, with a compound annual growth rate (CAGR) of 13.3% since 2020.
Adjusted EBITDA Projected at $126.1 million, up 38.9% year-over-year, with a CAGR of 13.6%.
Net Debt-to-Asset Ratio 49.2%, maintaining a balanced capital structure.
Dividend $0.16 a share, representing a 5.2% yield. This is a 14% increase over previous quarters.
Acquisition of 9 skilled nursing facilities: Completed acquisition of 9 skilled nursing facilities with 686 beds in Missouri for $59 million on July 1, 2025.
Acquisition of skilled nursing facility in Oklahoma: Acquired a skilled nursing facility with 80 licensed beds near McLoud, Oklahoma, for $4.25 million on August 5, 2025. Initial annual base rents are $425,000 with 3% annual rent increases.
Acquisition of healthcare facility in Missouri: Acquired a healthcare facility with 108 skilled nursing beds and 16 assisted living beds near Poplar Bluff, Missouri, for $5.3 million on August 29, 2025. Initial annual base rents are $530,000 with 3% annual rent increases.
Expansion into new states: Company is exploring expansion into new states like Georgia, Mississippi, and Alabama, focusing on sizable portfolios of at least 500 beds.
Diversification: Portfolio is diversified across 10 states, with no single state or tenant exceeding 25% of the portfolio.
Dividend increase: Board approved a 14% increase in dividend to $0.16 per share for Q3 2025, maintaining a payout ratio of 46.8%.
Revenue growth: Year-to-date revenue through September 2025 was $114.9 million, up $28.3 million from the previous year, driven by acquisitions and retenanting activities.
AFFO and EBITDA growth: Projected AFFO for 2025 is $72.7 million, a 28.2% increase year-over-year. Adjusted EBITDA is projected at $126.1 million, up 38.9% year-over-year.
Focus on skilled nursing facilities: 91.5% of the portfolio consists of skilled nursing facilities, making it the closest pure-play skilled nursing REIT in the market.
Master lease structure: 89% of facilities are under master leases, allowing for streamlined operations and potential for growth in existing states.
Acquisition Strategy: The company’s aggressive acquisition strategy, while driving growth, has led to higher expenses, including depreciation, amortization, and interest. This could strain financial resources and impact profitability if not managed carefully.
Debt Management: The company’s net debt-to-asset ratio is 49.2%, and 23% of its debt is variable rate. Rising interest rates could increase financing costs, impacting cash flow and profitability.
Tenant Concentration: Although diversified across 10 states, Indiana represents 25% of the portfolio, creating potential risks if market conditions or regulations in that state change unfavorably.
Economic and Regulatory Risks: The business relies heavily on government-funded healthcare programs. Changes in government policies or funding levels could adversely affect tenant operations and rent collections.
Market Expansion Challenges: The company’s strategy to expand into new states requires acquiring sizable portfolios, which may limit flexibility and delay growth if suitable opportunities are not available.
Foreign Currency Exchange Losses: The company experienced foreign currency exchange losses, which could continue to impact other comprehensive income if not mitigated.
Stock Undervaluation: The company’s stock is trading at a lower AFFO multiple compared to peers, which may limit its ability to raise equity capital efficiently.
Projected AFFO for 2025: $72.7 million, a 28.2% increase over the last year with a compound annual growth rate (CAGR) of 13.3% since 2020.
Adjusted EBITDA for 2025: Projected at $126.1 million, up 38.9% year-over-year with a 13.6% CAGR.
Acquisition Pipeline: Currently in excess of $250 million, with plans to spend $150 million to $160 million annually on acquisitions.
Dividend Growth: Dividend payout ratio maintained below 50%, with plans to continue raising dividends incrementally as profitability grows.
Market Expansion: Plans to expand into new states, particularly in the Southeast (e.g., Mississippi, Alabama, Georgia), with a focus on acquiring sizable portfolios of at least 500 beds.
Capital Raise: Plans to conduct a capital raise to attract institutional investors and increase stock liquidity.
Debt Management: Debt is diversified across HUD, bond, and bank debt, with only 23% variable rate. Plans to use debt strategically for growth while maintaining leverage below 50%.
Market Trends: Positioned to benefit from demographic trends, particularly the aging baby boomer population, which is expected to drive demand for skilled nursing facilities.
Dividend Increase: During Q3, the Board of Directors approved increasing the dividend to $0.16 a share, representing a 14% increase over previous quarters.
Q4 Dividend Approval: The Board of Directors approved the Q4 2024 dividend, which will also be $0.16 a share, to be paid on December 30 to shareholders of record on December 16.
Dividend Yield: As of September 30, the dividend yield was 5.2%, with an AFFO payout ratio of 46.8%.
Dividend Growth: The company has raised its dividend 5 to 6 times and plans to continue this trend, maintaining a payout ratio below 50%.
The earnings call indicates strong financial performance with increased revenue, net income, and dividend growth. The company has a balanced capital structure and plans for further acquisition growth. The Q&A section reveals proactive management strategies, including refinancing plans and strategic divestitures. Despite some unclear responses, the overall sentiment from the earnings and Q&A is positive, bolstered by dividend increases and acquisition plans. The lack of negative sentiment in analyst questions and management's optimistic outlook suggest a positive stock price movement in the short term.
The earnings call presents a positive outlook with strong revenue growth, significant dividend increases, and successful capital raising efforts. Despite the public offering, the company's strategic acquisitions and consistent dividend policy indicate stability and growth. The Q&A section reveals management's confidence in maintaining leverage and securing financing, although there is some uncertainty around Medicaid percentage increases. Overall, the financial performance and strategic initiatives suggest a positive stock price movement in the short term.
The earnings call summary reveals strong financial performance, with increased revenue, net income, and dividends, alongside strategic acquisitions. The Q&A session highlights a robust deal pipeline and confidence in leverage management. While there is uncertainty about the Medicaid payer mix, overall sentiment remains positive due to growth in assets and shareholder returns, despite the public offering potentially diluting shares. The absence of a market cap suggests a neutral to positive reaction, but given the strong financials and optimistic guidance, a 'Positive' sentiment is appropriate.
The earnings call reveals positive financial performance, with increased assets, equity, and a higher dividend payout, indicating confidence in future growth. The Q&A section raised some concerns regarding Medicaid reimbursements, but overall sentiment remained positive, particularly with the expected FFO growth and base rent increase. The ATM program and increased liquidity are also favorable. While there are risks like regulatory issues and debt management, the optimistic guidance and shareholder return plan, coupled with a strong dividend history, suggest a positive stock price movement in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.